Anti-phospholipase A2 Receptor Antibody Measurement in Patients with Idiopathic Membranous Nephropathy Diagnosed by Renal Biopsy

Journal Title: European Journal of Therapeutics - Year 2023, Vol 29, Issue 2

Abstract

Objective: Our study is a cross-sectional study that aims to evaluate the presence and levels of anti-phospholipase A2 receptor (PLA2R) antibodies in healthy volunteers and idiopathic membranous nephropathy (IMN) patients and to assess the relationship between these levels and clinical parameters. Methods: Serum anti-PLA2R antibody levels, complete blood count, urea, creatinine (Kre), total protein,albumin, low-density lipoprotein (LDL)-cholesterol, triglycerides (TG), high-density lipoprotein (HDL)-cholesterol, total cholesterol, C-reactive protein (crp), sedimentation, proteinuria were measured from 71 IMN patients and 48 healthy volunteers. Results: Of the values compared between the two groups, the urea, creatinine, and modified diet renal disease (MDRD) were similar, total protein, albumin, LDL-cholesterol, TG, total cholesterol, HDL-cholesterol, and complete urinalysis protein values were statistically significantly high in the patient group, as expected in nephrotic syndrome (p<0.01). The anti-PLA2Rantibody levels measured using enzyme-linked immunosorbent assay (ELISA) in patient and control groups were found to be negative. The anti-PLA2R level was found to be 0.104 (0.093-0.129) ng/ml in the IMN group, while it was 0.141 (0.117-0.177) ng/ml in the control group (P=0,001). Although the P value was significant, the anti-PLA2R antibody level was found to be high in the control group and was outside the reference range of the kit. Conclusion: There is a need to conduct more sensitive studies with a higher number of patients in order to distinguish between primary and secondary nature and to investigate the presence of anti-PLA2R in IMNpatients, which constitute the majority of nephrotic syndromes in adults. Antibody titer levels were observed to be low and it was revealed that the measurement range of the antibody kit used in the study should be more sensitive.

Authors and Affiliations

Sadettin Öztürk, Ozlem Usalan, Celalettin Usalan, Orhan Ozdemir

Keywords

Related Articles

The Reliability of the Projection Area Per Length Squared for Measuring Lumbar Lordosis on Lateral Radiographs: A Comparison with Cobb Method

Objective: The assessment of the degree of lumbar lordosis in patients with spinal disorders is essential to determine disease progression and the effectiveness of treatment. The aim of this study was to examine the rel...

Attenuation of Senescence-Induced Oxidative Exacerbations in Aged Rat Testis by Ferula Elaeochytris Root Extract

Objective: Age brings about changes to the oxidant and antioxidant balance of male testis that give rise to loss of fertility. The Ferula elaeochytris root extract (FE), contents antioxidant and anti-inflammatory compon...

Scary Acute Left Main Coronary Artery Thrombus as an Initial Presentation of a Hereditary Thrombophilia: When to Go Out of Routine?

Patients with either hereditary or acquired thrombophilia can present with arterial and venous thrombotic complications. However, it is unclear to whom the thrombophilia panel should be assessed, particularly in patient...

Serum Nuclear Factor Erythroid-2 Related Factor-2 (NRF2) as an Indicator of Oxidative Stress is Related to Coronary in-Stent Restenosis

Objective: In the treatment of coronary artery disease, stent implantation has become the standard treatment, but development of in-stent restenosis (ISR) limits the benefit of this treatment modality. Methods: Based...

Polypharmacy and Depression Among Older Individuals

Objective: The aim of the present study is to determine the frequency of polypharmacy and depression and the relationship between them in older adults. Methods: We reviewed the files and electronic records of 863 pati...

Download PDF file
  • EP ID EP720445
  • DOI -
  • Views 37
  • Downloads 0

How To Cite

Sadettin Öztürk, Ozlem Usalan, Celalettin Usalan, Orhan Ozdemir (2023). Anti-phospholipase A2 Receptor Antibody Measurement in Patients with Idiopathic Membranous Nephropathy Diagnosed by Renal Biopsy. European Journal of Therapeutics, 29(2), -. https://europub.co.uk/articles/-A-720445